These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


175 related items for PubMed ID: 22643214

  • 1. Simultaneous quantification of the viral antigens hemagglutinin and neuraminidase in influenza vaccines by LC-MSE.
    Creskey MC, Li C, Wang J, Girard M, Lorbetskie B, Gravel C, Farnsworth A, Li X, Smith DG, Cyr TD.
    Vaccine; 2012 Jul 06; 30(32):4762-70. PubMed ID: 22643214
    [Abstract] [Full Text] [Related]

  • 2. Simultaneous quantification of hemagglutinin and neuraminidase of influenza virus using isotope dilution mass spectrometry.
    Williams TL, Pirkle JL, Barr JR.
    Vaccine; 2012 Mar 23; 30(14):2475-82. PubMed ID: 22197963
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Development and fit-for-purpose verification of an LC-MS method for quantitation of hemagglutinin and neuraminidase proteins in influenza virus-like particle vaccine candidates.
    Guo J, Lu Y, Zhang Y, Mugabe S, Wei Z, Borisov OV.
    Anal Biochem; 2020 Mar 01; 592():113577. PubMed ID: 31926146
    [Abstract] [Full Text] [Related]

  • 5. Label-free mass spectrometry-based quantification of hemagglutinin and neuraminidase in influenza virus preparations and vaccines.
    Getie-Kebtie M, Sultana I, Eichelberger M, Alterman M.
    Influenza Other Respir Viruses; 2013 Jul 01; 7(4):521-30. PubMed ID: 22943763
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. An alternative method for preparation of pandemic influenza strain-specific antibody for vaccine potency determination.
    Schmeisser F, Vodeiko GM, Lugovtsev VY, Stout RR, Weir JP.
    Vaccine; 2010 Mar 11; 28(12):2442-9. PubMed ID: 20074687
    [Abstract] [Full Text] [Related]

  • 8. Avian glycan-specific IgM monoclonal antibodies for the detection and quantitation of type A and B haemagglutinins in egg-derived influenza vaccines.
    Legastelois I, Chevalier M, Bernard MC, de Montfort A, Fouque M, Pilloud A, Serraille C, Devard N, Engel O, Sodoyer R, Moste C.
    J Virol Methods; 2011 Dec 11; 178(1-2):129-36. PubMed ID: 21907241
    [Abstract] [Full Text] [Related]

  • 9. Optimization and qualification of a quantitative reversed-phase HPLC method for hemagglutinin in influenza preparations and its comparative evaluation with biochemical assays.
    Lorbetskie B, Wang J, Gravel C, Allen C, Walsh M, Rinfret A, Li X, Girard M.
    Vaccine; 2011 Apr 18; 29(18):3377-89. PubMed ID: 21397719
    [Abstract] [Full Text] [Related]

  • 10. Quantitative analyses of all influenza type A viral hemagglutinins and neuraminidases using universal antibodies in simple slot blot assays.
    Gravel C, Li C, Wang J, Hashem AM, Jaentschke B, Van Domselaar G, He R, Li X.
    J Vis Exp; 2011 Apr 04; (50):. PubMed ID: 21490585
    [Abstract] [Full Text] [Related]

  • 11. Haemagglutinin quantification and identification of influenza A&B strains propagated in PER.C6 cells: a novel RP-HPLC method.
    Kapteyn JC, Saidi MD, Dijkstra R, Kars C, Tjon JC, Weverling GJ, de Vocht ML, Kompier R, van Montfort BA, Guichoux JY, Goudsmit J, Lagerwerf FM.
    Vaccine; 2006 Apr 12; 24(16):3137-44. PubMed ID: 16490287
    [Abstract] [Full Text] [Related]

  • 12. Immunization against influenza A virus: comparison of conventional inactivated, live-attenuated and recombinant baculovirus produced purified hemagglutinin and neuraminidase vaccines in a murine model system.
    Brett IC, Johansson BE.
    Virology; 2005 Sep 01; 339(2):273-80. PubMed ID: 15996702
    [Abstract] [Full Text] [Related]

  • 13. Quantification of influenza virus hemagglutinins in complex mixtures using isotope dilution tandem mass spectrometry.
    Williams TL, Luna L, Guo Z, Cox NJ, Pirkle JL, Donis RO, Barr JR.
    Vaccine; 2008 May 12; 26(20):2510-20. PubMed ID: 18440105
    [Abstract] [Full Text] [Related]

  • 14. Quantification of immunoreactive viral influenza proteins by immunoaffinity capture and isotope-dilution liquid chromatography-tandem mass spectrometry.
    Pierce CL, Williams TL, Moura H, Pirkle JL, Cox NJ, Stevens J, Donis RO, Barr JR.
    Anal Chem; 2011 Jun 15; 83(12):4729-37. PubMed ID: 21591780
    [Abstract] [Full Text] [Related]

  • 15. Development and qualification of the parallel line model for the estimation of human influenza haemagglutinin content using the single radial immunodiffusion assay.
    van Kessel G, Geels MJ, de Weerd S, Buijs LJ, de Bruijni MA, Glansbeek HL, van den Bosch JF, Heldens JG, van den Heuvel ER.
    Vaccine; 2012 Jan 05; 30(2):201-9. PubMed ID: 22107849
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Estimation of the neuraminidase content of influenza viruses and split-product vaccines by immunochromatography.
    Tanimoto T, Nakatsu R, Fuke I, Ishikawa T, Ishibashi M, Yamanishi K, Takahashi M, Tamura S.
    Vaccine; 2005 Aug 31; 23(37):4598-609. PubMed ID: 15964668
    [Abstract] [Full Text] [Related]

  • 18. Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin.
    Bright RA, Carter DM, Daniluk S, Toapanta FR, Ahmad A, Gavrilov V, Massare M, Pushko P, Mytle N, Rowe T, Smith G, Ross TM.
    Vaccine; 2007 May 10; 25(19):3871-8. PubMed ID: 17337102
    [Abstract] [Full Text] [Related]

  • 19. Co-administration of certain DNA vaccine combinations expressing different H5N1 influenza virus antigens can be beneficial or detrimental to immune protection.
    Patel A, Gray M, Li Y, Kobasa D, Yao X, Kobinger GP.
    Vaccine; 2012 Jan 11; 30(3):626-36. PubMed ID: 22119588
    [Abstract] [Full Text] [Related]

  • 20. Influenza viral neuraminidase: the forgotten antigen.
    Johansson BE, Cox MM.
    Expert Rev Vaccines; 2011 Dec 11; 10(12):1683-95. PubMed ID: 22085172
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.